Compare DNTH & VIPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNTH | VIPS |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.1B |
| IPO Year | 2018 | 2012 |
| Metric | DNTH | VIPS |
|---|---|---|
| Price | $77.07 | $12.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 21 |
| Target Price | ★ $140.80 | $16.02 |
| AVG Volume (30 Days) | 865.0K | ★ 2.1M |
| Earning Date | 11-04-2026 | 11-19-2026 |
| Dividend Yield | N/A | ★ 4.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.87 |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.28 | $12.02 |
| 52 Week High | $117.88 | $20.49 |
| Indicator | DNTH | VIPS |
|---|---|---|
| Relative Strength Index (RSI) | 33.18 | 44.98 |
| Support Level | $75.50 | $12.12 |
| Resistance Level | $91.36 | $12.81 |
| Average True Range (ATR) | 4.05 | 0.32 |
| MACD | 0.51 | 0.01 |
| Stochastic Oscillator | 40.47 | 20.76 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.